Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: A retrospective analysis

Transplantation

Volumn 98, Issue 10, 2014, Pages 1119-1127

  Novitzky, Dimitri ^a   Mi, Zhibao ^b   Sun, Qing ^c   Collins, Joseph F ^b   Cooper, David K C ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Brain death; Insulin; Organ donors; Thyroid hormone; Transplantation

Indexed keywords

LIOTHYRONINE; THYROXINE;

ADULT; AGE; ARTICLE; BODY MASS; BRAIN DEATH; CAUSE OF DEATH; CONTROLLED STUDY; ETHNICITY; FEMALE; GENDER; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART; HORMONAL THERAPY; HUMAN; INTESTINE; KIDNEY; LUNG; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PANCREAS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADOLESCENT; DONOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; SURVIVAL; TIME; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN DEATH; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROXINE; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84927712478     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000187     Document Type: Article

References (25)

1. Novitzky D, Wicomb WN, Cooper DKC, et al. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the Chacma baboon. J Heart Transplant 1984;4:63.
2. Cooper DKC, Novitzky D, Wicomb WN, et al. A review of studies relating to thyroid hormone therapy in brain-dead organ donors. Front Biosci (Landmark Ed) 2009;14:3750.
3. Novitzky D, Cooper DKC, Morrell D, et al. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine (T3) therapy. Transplantation 1988;45:32.
4. Novitzky D, Cooper DKC, Reichart B. Value of triiodothyronine (T3) therapy to brain-dead potential organ donors. J Heart Transplant 1986;5:486.
5. Novitzky D, Cooper DKC, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987;43:852.
6. Novitzky D, Cooper DKC, eds. The Brain-Dead Organ Donor: Pathophysiology and Management. New York, NY: Springer; 2013.
7. Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City Meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002;2:701.
8. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, VA. Circulation 2002;106:836.
9. Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002;2:761.
10. Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacological donor management results in more transplanted organs. Transplantation 2003;75:482.
11. Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts with improved early function. Transplantation 2003;75:1336.
12. Novitzky D, Cooper DKC, Rosendale JD, et al. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 2006;82:1396.
13. Canadian Council for Donation and Transplantation (CCDT) Summative Evaluation Final Report. Barrington GV. 2006.
14. UNOS Standard Transplant Analysis and Research (STAR) Files. Available at http://optn. transplant.hrsa.gov/data/request-main. asp?refer=true. Accessed May 7, 2014.
15. Macdonald PS, Aneman A, Bhonagiri D, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med 2012;40:1635.
16. Rech TH, Moraes RB, Crispin D, et al. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation 2013;95:966.
17. Salim A, Veimahos GC, Brown C, et al. Aggressive organ donor management significantly increases the number of organs available for transplantation. J Trauma 2005;58:991.
18. Salim A, Martin M, Brown C, et al. Using thyroid hormone in braindead donors to maximize the number of organs available for transplantation. Clin Transplant 2007;21:405.
19. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65.
20. Abdelnour T, Rieke S. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant. J Heart Lung Transplant 2009;28:480.
21. Hughes C, Can M, Lopez R, et al. Thyroxin Administration During Donor Management is Associated With Improved Graft Survival in Adult Liver Transplant Recipients. Boston, MD: American Transplant Congress; 2012: Abstract #343.
22. Dumont JE, Maenhaut C, Lamy F, et al. Growth and proliferation of the thyroid cell in normal physiology and in disease. Ann Endocrinol (Paris) 2003;64:10.
23. Shapiro LE, Baron T. Thyroid function in health and disease, with particular reference to brain death. In: Novitzky D, Cooper DKC, eds. The Brain-Dead Organ Donor: Pathophysiology and Management. New York, NY: Springer; 2012:91-105.
24. Novitzky D, Cooper DKC, Human PA, et al. Triiodothyronine therapy for heart donor and recipient. J Heart Transplant 1988;7:370.
25. Novitzky D, Cooper DKC, Chaffin JS, et al. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990;49:311.